Pulmonary Complications of Rheumatoid Arthritis

Hamish Farquhar, Robert Vassallo, Adrienne L. Edwards, Eric Lawrence Matteson

Research output: Contribution to journalReview article

Abstract

Rheumatoid arthritis (RA) is a common chronic autoimmune disorder that characteristically causes joint inflammation and damage. In addition, many patients develop extraarticular manifestations which may cause significant comorbidity and premature mortality. Some respiratory tract involvement of the upper and lower airways and parenchymal disease features are unique to RA, including cricoarytenoid arthritis and RA pulmonary nodulosis, and others, especially the interstitial parenchymal involvement, occur in many other idiopathic and autoimmune diseases. The pathophysiology of lung disease is not well understood. Rheumatoid lung disease may even predate the onset of joint disease, and could be triggered by chronic airway and alveolar epithelial injury. Chronic systemic inflammation and risk factors such as cigarette smoking, infection, host genetics, and immune dysregulation are contributors. Treatment of the respiratory disease is directed at reducing the systemic inflammation of RA. Less well understood is the management of the interstitial lung disease of RA, for which antifibrotic and immune suppressive agents may be helpful. The management of RA-related lung disease is perhaps the major remaining hurdle in reduction of the disease burden related to extraarticular manifestations of this disease.

Original languageEnglish (US)
Pages (from-to)194-207
Number of pages14
JournalSeminars in Respiratory and Critical Care Medicine
Volume40
Issue number2
DOIs
StatePublished - Jan 1 2019
Externally publishedYes

Fingerprint

Rheumatoid Arthritis
Lung
Lung Diseases
Inflammation
Premature Mortality
Joint Diseases
Interstitial Lung Diseases
Prednisolone
Respiratory System
Autoimmune Diseases
Arthritis
Comorbidity
Joints
Smoking
Wounds and Injuries
Infection
Therapeutics

Keywords

  • airways disease
  • diagnosis
  • interstitial lung disease
  • lung disease
  • pathology
  • rheumatoid arthritis
  • treatment

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Cite this

Pulmonary Complications of Rheumatoid Arthritis. / Farquhar, Hamish; Vassallo, Robert; Edwards, Adrienne L.; Matteson, Eric Lawrence.

In: Seminars in Respiratory and Critical Care Medicine, Vol. 40, No. 2, 01.01.2019, p. 194-207.

Research output: Contribution to journalReview article

@article{3c81cf562cc24427bf46679058cf2461,
title = "Pulmonary Complications of Rheumatoid Arthritis",
abstract = "Rheumatoid arthritis (RA) is a common chronic autoimmune disorder that characteristically causes joint inflammation and damage. In addition, many patients develop extraarticular manifestations which may cause significant comorbidity and premature mortality. Some respiratory tract involvement of the upper and lower airways and parenchymal disease features are unique to RA, including cricoarytenoid arthritis and RA pulmonary nodulosis, and others, especially the interstitial parenchymal involvement, occur in many other idiopathic and autoimmune diseases. The pathophysiology of lung disease is not well understood. Rheumatoid lung disease may even predate the onset of joint disease, and could be triggered by chronic airway and alveolar epithelial injury. Chronic systemic inflammation and risk factors such as cigarette smoking, infection, host genetics, and immune dysregulation are contributors. Treatment of the respiratory disease is directed at reducing the systemic inflammation of RA. Less well understood is the management of the interstitial lung disease of RA, for which antifibrotic and immune suppressive agents may be helpful. The management of RA-related lung disease is perhaps the major remaining hurdle in reduction of the disease burden related to extraarticular manifestations of this disease.",
keywords = "airways disease, diagnosis, interstitial lung disease, lung disease, pathology, rheumatoid arthritis, treatment",
author = "Hamish Farquhar and Robert Vassallo and Edwards, {Adrienne L.} and Matteson, {Eric Lawrence}",
year = "2019",
month = "1",
day = "1",
doi = "10.1055/s-0039-1683995",
language = "English (US)",
volume = "40",
pages = "194--207",
journal = "Seminars in Respiratory and Critical Care Medicine",
issn = "1069-3424",
publisher = "Thieme Medical Publishers",
number = "2",

}

TY - JOUR

T1 - Pulmonary Complications of Rheumatoid Arthritis

AU - Farquhar, Hamish

AU - Vassallo, Robert

AU - Edwards, Adrienne L.

AU - Matteson, Eric Lawrence

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Rheumatoid arthritis (RA) is a common chronic autoimmune disorder that characteristically causes joint inflammation and damage. In addition, many patients develop extraarticular manifestations which may cause significant comorbidity and premature mortality. Some respiratory tract involvement of the upper and lower airways and parenchymal disease features are unique to RA, including cricoarytenoid arthritis and RA pulmonary nodulosis, and others, especially the interstitial parenchymal involvement, occur in many other idiopathic and autoimmune diseases. The pathophysiology of lung disease is not well understood. Rheumatoid lung disease may even predate the onset of joint disease, and could be triggered by chronic airway and alveolar epithelial injury. Chronic systemic inflammation and risk factors such as cigarette smoking, infection, host genetics, and immune dysregulation are contributors. Treatment of the respiratory disease is directed at reducing the systemic inflammation of RA. Less well understood is the management of the interstitial lung disease of RA, for which antifibrotic and immune suppressive agents may be helpful. The management of RA-related lung disease is perhaps the major remaining hurdle in reduction of the disease burden related to extraarticular manifestations of this disease.

AB - Rheumatoid arthritis (RA) is a common chronic autoimmune disorder that characteristically causes joint inflammation and damage. In addition, many patients develop extraarticular manifestations which may cause significant comorbidity and premature mortality. Some respiratory tract involvement of the upper and lower airways and parenchymal disease features are unique to RA, including cricoarytenoid arthritis and RA pulmonary nodulosis, and others, especially the interstitial parenchymal involvement, occur in many other idiopathic and autoimmune diseases. The pathophysiology of lung disease is not well understood. Rheumatoid lung disease may even predate the onset of joint disease, and could be triggered by chronic airway and alveolar epithelial injury. Chronic systemic inflammation and risk factors such as cigarette smoking, infection, host genetics, and immune dysregulation are contributors. Treatment of the respiratory disease is directed at reducing the systemic inflammation of RA. Less well understood is the management of the interstitial lung disease of RA, for which antifibrotic and immune suppressive agents may be helpful. The management of RA-related lung disease is perhaps the major remaining hurdle in reduction of the disease burden related to extraarticular manifestations of this disease.

KW - airways disease

KW - diagnosis

KW - interstitial lung disease

KW - lung disease

KW - pathology

KW - rheumatoid arthritis

KW - treatment

UR - http://www.scopus.com/inward/record.url?scp=85066634874&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066634874&partnerID=8YFLogxK

U2 - 10.1055/s-0039-1683995

DO - 10.1055/s-0039-1683995

M3 - Review article

C2 - 31137060

AN - SCOPUS:85066634874

VL - 40

SP - 194

EP - 207

JO - Seminars in Respiratory and Critical Care Medicine

JF - Seminars in Respiratory and Critical Care Medicine

SN - 1069-3424

IS - 2

ER -